Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-04T20:26:21.550Z Has data issue: false hasContentIssue false

Chapter 6 - Low-grade and intermediate-grade malignant epithelial tumors of the thymus: thymomas

Published online by Cambridge University Press:  05 February 2015

By
Alberto M. Marchevsky ,
Saul Suster  and
Mark R. Wick
Edited by
Alberto M. Marchevsky  and
Mark R. Wick
Alberto M. Marchevsky
Affiliation:
Cedars-Sinai Medical Center, Los Angeles
Saul Suster
Affiliation:
Medical College of Wisconsin
Mark R. Wick
Affiliation:
University of Virginia Health System
Alberto M. Marchevsky
Affiliation:
Cedars-Sinai Medical Center, Los Angeles
Mark R. Wick
Affiliation:
University of Virginia
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Pathology of the Mediastinum , pp. 65 - 103
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Shimosato, Y, Mukai, K, Matsuno, Y. Tumors of the Mediastinum. 2010; Washington: American Registry of Pathology.Google Scholar
Marchevsky, AM, Kaneko, M. Surgical Pathology of the Mediastinum. 1991; New York: Raven Press.Google Scholar
Marx, A, Muller-Hermelink, HK, Strobel, P. The role of thymomas in the development of myasthenia gravis. Ann N Y Acad Sci. 2003;998:223–36.CrossRefGoogle ScholarPubMed
Marx, A, Schultz, A, Wilisch, A et al. Paraneoplastic autoimmunity in thymus tumors. Dev Immunol. 1998;6:129–40.CrossRefGoogle ScholarPubMed
Marx, A, Willcox, N, Leite, MI et al. Thymoma and paraneoplastic myasthenia gravis. Autoimmunity. 2010;43:413–27.CrossRefGoogle ScholarPubMed
Levine, GD, Rosai, J. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol. 1978;9:495–515.CrossRefGoogle ScholarPubMed
Rosai, J. Thymomas, committees, and memory lapses. Am J Clin Pathol. 2011;135:648.CrossRefGoogle ScholarPubMed
Rosai, J. The pathology of thymic neoplasia. Monogr Pathol. 1987;161–83.
Finsterer, J, Mullauer, L. Is resection of a thymoma WHO A indicated in the absence of myasthenia gravis?Clin Ter. 2011;162:37–9.Google ScholarPubMed
Jain, RK, Mehta, RJ, Henley, JD et al. WHO types A and AB thymomas: not always benign. Mod Pathol. 2010;23:1641–9.CrossRefGoogle Scholar
Moran, CA, Kalhor, N, Suster, S. Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases. Am J Clin Pathol. 2010;134:793–8.CrossRefGoogle ScholarPubMed
Suster, S, Moran, CA. Histologic classification of thymoma: the World Health Organization and beyond. Hematol Oncol Clin North Am. 2008;22:381–92.CrossRefGoogle ScholarPubMed
Suster, S. Problem areas and inconsistencies in the WHO classification of thymoma. Semin Diagn Pathol. 2005;22:188–97.CrossRefGoogle ScholarPubMed
Suster, S. Thymoma classification: current status and future trends. Am J Clin Pathol. 2006;125:542–54.CrossRefGoogle ScholarPubMed
Koksal, D, Bayiz, H, Mutluay, N et al. Fibrosing mediastinitis mimicking bronchogenic carcinoma. J Thorac Dis. 2013;5:E5–E7.Google ScholarPubMed
Strobel, P, Hohenberger, P, Marx, A. Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol. 2010;5:S286–S290.CrossRefGoogle ScholarPubMed
Travis, WD, Brambilla, E, Muller-Hermelink, HK et al. Tumours of the Lung, Pleura, Thymus and Heart. 2004; Lyon: IARC Press.Google Scholar
LeGolvan, DP, Abell, MR. Thymomas. Cancer. 1977;39:2142–57.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Engels, EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5:S260–S265.CrossRefGoogle ScholarPubMed
Wick, MR, Scheithauer, BW, Dines, DE. Thymic neoplasia in two male siblings. Mayo Clin Proc. 1982;57:653–6.Google ScholarPubMed
Pascuzzi, RM, Sermas, A, Phillips, LH et al. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers. Neurology. 1986;36:423–7.CrossRefGoogle ScholarPubMed
Walter, E, Wilich, E, Webb, WR. The Thymus: Diagnostic Imaging, Functions and Pathologic Anatomy (Medical Radiology/Diagnostic Imaging). 2012; New York: Springer.Google Scholar
Heitzman, ER. The Mediastinum: Radiologic Correlations with Pathology. 2012; New York: Springer.Google Scholar
Hwang, JT, Kim, MH, Chang, KJ et al. A case of invasive thymoma with endotracheal polypoid growth. Tuberc Respir Dis (Seoul). 2012;73:331–5.CrossRefGoogle ScholarPubMed
Lavini, C, Moran, CA, Morandi, U et al. Thymus Gland Pathology: Clinical, Diagnostic and Therapeutic. 2008; New York: Springer.CrossRefGoogle Scholar
Lewis, JE, Wick, MR, Scheithauer, BW et al. Thymoma. A clinicopathologic review. Cancer. 1987;60:2727–43.3.0.CO;2-D>CrossRefGoogle ScholarPubMed
Kurata, A, Saji, H, Ikeda, N et al. Intracaval and intracardiac extension of invasive thymoma complicated by superior and inferior vena cava syndrome. Pathol Int. 2013;63:56–62.CrossRefGoogle ScholarPubMed
Yalcin, B, Demir, HA, Ciftci, AO et al. Thymomas in childhood: 11 cases from a single institution. J Pediatr Hematol Oncol. 2012;34:601–5.CrossRefGoogle ScholarPubMed
Toker, A, Tireli, E, Tanju, S et al. Transcaval invasion of right atrium by thymoma: resection via transient cava-pulmonary shunt. Eur J Cardiothorac Surg. 2012;41:1175–7.CrossRefGoogle ScholarPubMed
Rosa, GR, Takizawa, N, Schimidt, D et al. Surgical treatment of superior vena cava syndrome caused by invasive thymoma. Rev Bras Cir Cardiovasc. 2010;25:257–60.CrossRefGoogle ScholarPubMed
Tormoehlen, LM, Pascuzzi, RM. Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am. 2008;22:509–26.CrossRefGoogle ScholarPubMed
Weigert, C. Pathogisch-Anatomischer Beirtrag zur Erbschen Krankhei. Neurol Zentralbl. 1901;597.Google Scholar
Strobel, P, Preisshofen, T, Helmreich, M et al. Pathomechanisms of paraneoplastic myasthenia gravis. Clin Dev Immunol. 2003;10:7–12.CrossRefGoogle ScholarPubMed
Strobel, P, Helmreich, M, Menioudakis, G et al. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. Blood. 2002;100:159–66.CrossRefGoogle ScholarPubMed
Spuler, S, Sarropoulos, A, Marx, A et al. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice. Am J Pathol. 1996;148:1359–65.Google ScholarPubMed
Muller-Hermelink, HK, Marx, A, Geuder, K et al. The pathological basis of thymoma-associated myasthenia gravis. Ann N Y Acad Sci. 1993;681:56–65.CrossRefGoogle ScholarPubMed
Mao, ZF, Mo, XA, Qin, C et al. Incidence of thymoma in myasthenia gravis: a systematic review. J Clin Neurol. 2012;8:161–9.CrossRefGoogle ScholarPubMed
Piccolo, G, Martino, G, Moglia, A et al. Autoimmune myasthenia gravis with thymoma following the spontaneous remission of stiff-man syndrome. Ital J Neurol Sci. 1990;11:177–80.CrossRefGoogle ScholarPubMed
de Castro, MA, de Castro, MA, Arantes, AM et al. Thymoma followed by aplastic anemia – two different responses to immunosuppressive therapy. Rev Bras Hematol Hemoter. 2011;33:476–7.CrossRefGoogle ScholarPubMed
Bajel, A, Ryan, A, Roy, S et al. Aplastic anaemia: autoimmune sequel of thymoma. Br J Haematol. 2009;147:591.CrossRefGoogle ScholarPubMed
Gaglia, A, Bobota, A, Pectasides, E et al. Successful treatment with cyclosporine of thymoma-related aplastic anemia. Anticancer Res. 2007;27:3025–8.Google ScholarPubMed
Coplu, L, Selcuk, ZT, Haznedaroglu, IC et al. Aplastic pancytopenia associated with thymoma. Ann Hematol. 2000;79:648–50.Google ScholarPubMed
van SA, Wirtz, PW, Verschuuren, JJ et al. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia. Curr Treat Options Neurol. 2013;15:224–39.Google Scholar
Kon, T, Mori, F, Tanji, K et al. Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma. Neuropathology. 2013 Jun;33(3):281–7. . E-pub 2012 Sep 19.CrossRefGoogle ScholarPubMed
Miyazaki, Y, Hirayama, M, Watanabe, H et al. Paraneoplastic encephalitis associated with myasthenia gravis and malignant thymoma. J Clin Neurosci. 2012;19:336–8.CrossRefGoogle ScholarPubMed
Silvestri, NJ, Wolfe, GI. Myasthenia gravis. Semin Neurol. 2012;32:215–26.CrossRefGoogle ScholarPubMed
Wilkins, EW, Castleman, B. Thymoma: a continuing survey at the Massachusetts General Hospital. Ann Thorac Surg. 1979;28:252–6.CrossRefGoogle ScholarPubMed
az-Manera, J, Rojas, GR, Illa, I. Treatment strategies for myasthenia gravis: an update. Expert Opin Pharmacother. 2012;13:1873–83.CrossRefGoogle Scholar
Spaggiari, L, Casiraghi, M, Guarize, J. Multidisciplinary treatment of malignant thymoma. Curr Opin Oncol. 2012;24:117–22.CrossRefGoogle ScholarPubMed
Maclennan, CA, Vincent, A, Marx, A et al. Preferential expression of AChR epsilon-subunit in thymomas from patients with myasthenia gravis. J Neuroimmunol. 2008;201–2:28–32.CrossRefGoogle ScholarPubMed
Gattenlohner, S, Brabletz, T, Schultz, A et al. Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit from a thymoma associated with myasthenia gravis. Thymus. 1994;23:103–13.Google Scholar
Siara, J, Rudel, R, Marx, A. Absence of acetylcholine-induced current in epithelial cells from thymus glands and thymomas of myasthenia gravis patients. Neurology. 1991;41:128–31.CrossRefGoogle ScholarPubMed
Marx, A, O’Connor, R, Geuder, KI et al. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest. 1990;62:279–86.Google ScholarPubMed
Geuder, KI, Schoepfer, R, Kirchner, T et al. The gene of the alpha-subunit of the acetylcholine receptor: molecular organisation and transcription in myasthenia-associated thymomas. Thymus. 1989;14:179–86.Google ScholarPubMed
Marx, A, O’Connor, R, Tzartos, S et al. Acetylcholine receptor epitope in proteins of myasthenia gravis-associated thymomas and non-thymic tissues. Thymus. 1989;14:171–8.Google ScholarPubMed
Wilisch, A, Gutsche, S, Hoffacker, V et al. Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis. Neurology. 1999;52:1460–6.CrossRefGoogle ScholarPubMed
Marx, A, Wilisch, A, Schultz, A et al. Pathogenesis of myasthenia gravis. Virchows Arch. 1997;430:355–64.CrossRefGoogle ScholarPubMed
Judd, RL, Welch, SL. Myoid cell differentiation in true thymic hyperplasia and lymphoid hyperplasia. Arch Pathol Lab Med. 1988;112:1140–4.Google ScholarPubMed
Hayward, AR. Myoid cells in the human foetal thymus. J Pathol. 1972;106:45–8.CrossRefGoogle ScholarPubMed
Hayward, A. The detection of myoid cells in the human foetal and neonatal thymus by immunofluorescence.J Med Microbiol. 1970;3:v.Google ScholarPubMed
Ito, T, Hoshino, T, Abe, K. The fine structure of myoid cells in the human thymus. Arch Histol Jpn. 1969;30:207–15.CrossRefGoogle ScholarPubMed
Marx, A, Pfister, F, Schalke, B et al. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev. 2013.
Kirchner, T, Tzartos, S, Hoppe, F et al. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol. 1988;130:268–80.Google ScholarPubMed
Yang, H, Hao, J, Peng, X et al. The association of HLA-DQA1*0401 and DQB1*0604 with thymomatous myasthenia gravis in northern Chinese patients. J Neurol Sci. 2012;312:57–61.CrossRefGoogle ScholarPubMed
Kont, V, Murumagi, A, Tykocinski, LO et al. DNA methylation signatures of the AIRE promoter in thymic epithelial cells, thymomas and normal tissues. Mol Immunol. 2011;49:518–26.CrossRefGoogle ScholarPubMed
Deitiker, PR, Oshima, M, Smith, RG et al. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. Int J Immunogenet. 2011;38:55–62.CrossRefGoogle ScholarPubMed
Vandiedonck, C, Raffoux, C, Eymard, B et al. Association of HLA-A in autoimmune myasthenia gravis with thymoma. J Neuroimmunol. 2009;210:120–23.CrossRefGoogle ScholarPubMed
Santos, SG, Antoniou, AN, Sampaio, P et al. Lack of tyrosine 320 impairs spontaneous endocytosis and enhances release of HLA-B27 molecules. J Immunol. 2006;176:2942–9.CrossRefGoogle ScholarPubMed
Donmez, B, Ozakbas, S, Oktem, MA et al. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features. Hum Immunol. 2004;65:752–7.CrossRefGoogle ScholarPubMed
Antoniou, AN, Ford, S, Taurog, JD et al. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J Biol Chem. 2004;279:8895–902.CrossRefGoogle ScholarPubMed
Garcia-Ramos, G, Tellez-Zenteno, JF, Zapata-Zuniga, M et al. HLA class II genotypes in Mexican Mestizo patients with myasthenia gravis. Eur J Neurol. 2003;10:707–10.CrossRefGoogle ScholarPubMed
Machens, A, Loliger, C, Pichlmeier, U et al. Correlation of thymic pathology with HLA in myasthenia gravis. Clin Immunol. 1999;91:296–301.CrossRefGoogle ScholarPubMed
Vieira, ML, Caillat-Zucman, S, Gajdos, P et al. Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis. J Neuroimmunol. 1993;47:115–22.CrossRefGoogle ScholarPubMed
Zisimopoulou, P, Brenner, T, Trakas, N et al. Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. Autoimmun Rev. 2013; 12:924–30.CrossRefGoogle ScholarPubMed
Aysal, F, Baybas, S, Selcuk, HH et al. Paraneoplastic extralimbic encephalitis associated with thymoma and myasthenia gravis: Three years follow up. Clin Neurol Neurosurg. 2013;115:628–31.CrossRefGoogle ScholarPubMed
Beard, ME, Krantz, SB, Johnson, SA et al. Pure red cell aplasia. Q J Med. 1978;47:339–48.Google ScholarPubMed
Korn, D, Gelderman, A, Cage, G et al. Immune deficiencies, aplastic anemia and abnormalities of lymphoid tissue in thymoma. N Engl J Med. 1967;276:1333–9.CrossRefGoogle ScholarPubMed
Shibata, K, Masaoka, A, Mizuno, T et al. Pure red cell aplasia following irradiation of an asymptomatic thymoma. Jpn J Surg. 1982;12:419–23.CrossRefGoogle ScholarPubMed
Saha, M, Ray, S, Kundu, S et al. Pure red cell aplasia following autoimmune hemolytic anemia: An enigma. J Postgrad Med. 2013;59:51–3.Google Scholar
Balikar, R, Redkar, NN, Patil, MA et al. Myasthenia gravis and pure red cell aplasia: a rare association. BMJ Case Rep. 2013. .
Baral, A, Poudel, B, Agrawal, RK et al. Pure red cell aplasia caused by Parvo B19 virus in a kidney transplant recipient. JNMA J Nepal Med Assoc. 2012;52:75–8.Google Scholar
Sreenivasan, P, Mani, NS. Pure red cell aplasia in systemic onset juvenile idiopathic arthritis. Indian J Hematol Blood Transfus. 2012;28:42–3.CrossRefGoogle ScholarPubMed
Masaoka, A, Hashimoto, T, Shibata, K et al. Thymomas associated with pure red cell aplasia. Histologic and follow-up studies. Cancer. 1989;64:1872–8.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
Voigt, S. Polycytaemia vera associated with thymoma. Case report. Acta Pathol Microbiol Immunol Scand A. 1986;94:351–2.Google ScholarPubMed
Ertel, V, Fruh, M, Guenther, A et al. Thymoma with molecularly verified “conversion” into T lymphoblastic leukemia/lymphoma over nine years. Leuk Lymphoma. 2013.
Sichere, P, Galimard, E, Fromaget, M et al. Myeloma and thymoma: an as yet unreported association. Rev Rhum Engl Ed. 1997;64:518–19.Google Scholar
Weir, AB, Dow, LW. Response of agranulocytosis to thymectomy in a patient with thymoma and chronic lymphocytic leukemia. Med Pediatr Oncol. 1989;17:58–61.CrossRefGoogle Scholar
Davila, DG, Ryan, DH. Thymoma, hypogammaglobulinemia, and pernicious anemia. South Med J. 1986;79:904–6.CrossRefGoogle ScholarPubMed
Lyonnais, J. Thymoma and pancytopenia. Am J Hematol. 1988;28:195–6.CrossRefGoogle ScholarPubMed
Fitzmaurice, RJ, Gardner, DL. Thymoma with bone marrow eosinophilia. J R Soc Med. 1990;83:270–1.CrossRefGoogle ScholarPubMed
Kikuchi, R, Mino, N, Okamoto, T et al. A case of Good’s syndrome: a rare acquired immunodeficiency associated with thymoma. Ann Thorac Cardiovasc Surg. 2011;17:74–6.CrossRefGoogle ScholarPubMed
Waldmann, TA, Broder, S, Durm, M et al. Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymoma. Trans Assoc Am Physicians. 1975;88:120–34.Google ScholarPubMed
Habbe, N, Waldmann, J, Bartsch, DK et al. Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus. Surgery. 2008;144:780–5.CrossRefGoogle ScholarPubMed
Montes, LF, Ceballos, R, Cooper, MD et al. Chronic mucocutaneous candidiasis, myositis, and thymoma. A new triad. JAMA. 1972;222:1619–23.CrossRefGoogle ScholarPubMed
Kauffman, CA, Linnemann, CC, Alvira, MM. Cytomegalovirus encephalitis associated with thymoma and immunoglobulin deficiency. Am J Med. 1979;67:724–8.CrossRefGoogle ScholarPubMed
Kisand, K, Lilic, D, Casanova, JL, et al. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur J Immunol 2011;41(6):1517–727.CrossRefGoogle ScholarPubMed
Chen, PC, Pan, CC, Yang, AH et al. Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization. J Pathol. 2002;197:684–8.CrossRefGoogle ScholarPubMed
Borisch, B, Kirchner, T, Marx, A et al. Absence of the Epstein-Barr virus genome in the normal thymus, thymic epithelial tumors, thymic lymphoid hyperplasia in a European population. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;59:359–65.CrossRefGoogle Scholar
Inghirami, G, Chilosi, M, Knowles, DM. Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. Am J Pathol. 1990;136:1429–36.Google ScholarPubMed
McGuire, LJ, Huang, DP, Teoh, R et al. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am J Pathol. 1988;131:385–90.Google ScholarPubMed
Yoshida, M, Miyoshi, T, Sakiyama, S et al. Pemphigus with thymoma improved by thymectomy: report of a case. Surg Today. 2012; 20:479–81.Google Scholar
Rota, C, Lupi, F, De, PO et al. Pemphigus foliaceous with thymoma and multiple comorbidities: a fatal case. Eur J Dermatol. 2011;21:424–5.Google ScholarPubMed
Barbetakis, N, Samanidis, G, Paliouras, D et al. Paraneoplastic pemphigus regression after thymoma resection. World J Surg Oncol. 2008;6:83.CrossRefGoogle ScholarPubMed
Winkler, DT, Strnad, P, Meier, ML et al. Myasthenia gravis, paraneoplastic pemphigus and thymoma, a rare triade. J Neurol. 2007;254:1601–3.CrossRefGoogle ScholarPubMed
Gibson, LE, Muller, SA. Dermatologic disorders in patients with thymoma. Acta Derm Venereol. 1987;67:351–6.Google ScholarPubMed
Holbro, A, Jauch, A, Lardinois, D et al. High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol. 2012;73:287–90.CrossRefGoogle ScholarPubMed
Shelly, S, gmon-Levin, N, Altman, A et al. Thymoma and autoimmunity. Cell Mol Immunol. 2011;8:199–202.CrossRefGoogle ScholarPubMed
Sherer, Y, Bardayan, Y, Shoenfeld, Y. Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases (Review). Int J Oncol. 1997;10:939–43.Google Scholar
Yapali, S, Oruc, N, Ilgun, S et al. Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder. Hepatol Res. 2012;42:835–39.CrossRefGoogle Scholar
Karras, A, de Montpreville, V, Fakhouri, F et al. Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant. 2005;20:1075–82.CrossRefGoogle ScholarPubMed
Varsano, S, Bruderman, I, Bernheim, JL et al. Minimal-change nephropathy and malignant thymoma. Chest. 1980;77:695–7.CrossRefGoogle ScholarPubMed
Skinnider, LF, Alexander, S, Horsman, D. Concurrent thymoma and lymphoma: a report of two cases. Hum Pathol. 1982;13:163–6.CrossRefGoogle ScholarPubMed
Ridell, B, Larsson, S. Coexistence of a thymoma and Hodgkin’s disease of the thymus. A case report. Acta Pathol Microbiol Scand A. 1980;88:1–4.Google ScholarPubMed
Souadjian, JV, Silverstein, MN, Titus, JL. Thymoma and cancer. Cancer. 1968;22:1221–5.3.0.CO;2-7>CrossRefGoogle ScholarPubMed
Lesser, M, Mouli, CC, Jothikumar, T. Hypertrophic osteoarthropathy associated with a malignant thymoma. Mt Sinai J Med. 1980;47:24–30.Google ScholarPubMed
Palmer, FJ, Sawyers, TM. Hyperparathyroidism, chemodectoma, thymoma, and myasthenia gravis. Arch Intern Med. 1978;138:1402–3.CrossRefGoogle ScholarPubMed
Vincent, A, Waters, P, Leite, MI et al. Antibodies identified by cell-based assays in myasthenia gravis and associated diseases. Ann N Y Acad Sci. 2012;1274:92–8.CrossRefGoogle ScholarPubMed
Vernino, S, Lennon, VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004;10:7270–5.CrossRefGoogle ScholarPubMed
Smith, WF, DeWall, RA, Krumholz, RA. Giant thymoma. Chest. 1970;58:383–4.CrossRefGoogle ScholarPubMed
Rieker, RJ, Aulmann, S, Schnabel, PA et al. Cystic thymoma. Pathol Oncol Res. 2005;11:57–60.CrossRefGoogle ScholarPubMed
Moran, CA, Suster, S. Thymoma with prominent cystic and hemorrhagic changes and areas of necrosis and infarction: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2001;25:1086–90.CrossRefGoogle ScholarPubMed
Effler, DB, McCormack, LJ. Thymic neoplasms. J Thorac Surg. 1956;31:60–77.Google ScholarPubMed
Bernatz, PE, Harrison, EG, Clagett, OT. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg. 1961;42:424–44.Google ScholarPubMed
Snover, DC, Levine, GD, Rosai, J. Thymic carcinoma. Five distinctive histological variants. Am J Surg Pathol. 1982;6:451–70.CrossRefGoogle ScholarPubMed
Muller-Hermelink, HK, Marino, M, Palestro, G. Pathology of thymic epithelial tumors. Curr Top Pathol. 1986;75:207–68.CrossRefGoogle ScholarPubMed
Muller-Hermelink, HK, Marx, A. Towards a histogenetic classification of thymic epithelial tumours?Histopathology. 2000;36:466–9.CrossRefGoogle ScholarPubMed
Suster, S, Moran, CA. Thymoma classification. The ride of the valkyries?Am J Clin Pathol. 1999;112:308–10.CrossRefGoogle ScholarPubMed
Dadmanesh, F, Sekihara, T, Rosai, J. Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am. 2001;11:407–20.Google ScholarPubMed
Chalabreysse, L, Roy, P, Cordier, JF et al. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol. 2002;26:1605–11.CrossRefGoogle ScholarPubMed
Chen, G, Marx, A, Chen, WH et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95:420–9.CrossRefGoogle ScholarPubMed
Detterbeck, FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006;81:2328–34.CrossRefGoogle ScholarPubMed
Kondo, K, Yoshizawa, K, Tsuyuguchi, M et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77:1183–8.CrossRefGoogle ScholarPubMed
Okumura, M, Ohta, M, Miyoshi, S et al. Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg. 2002;50:189–94.CrossRefGoogle ScholarPubMed
Okumura, M, Miyoshi, S, Fujii, Y et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol. 2001;25:103–10.CrossRefGoogle ScholarPubMed
Sonobe, S, Miyamoto, H, Izumi, H et al. Clinical usefulness of the WHO histological classification of thymoma. Ann Thorac Cardiovasc Surg. 2005;11:367–73.Google ScholarPubMed
Moran, CA, Suster, S. The World Health Organization (WHO) histologic classification of thymomas: a reanalysis. Curr Treat Options Oncol. 2008;9:288–99.CrossRefGoogle ScholarPubMed
Suster, S, Moran, CA. Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol. 1999;111:826–33.CrossRefGoogle ScholarPubMed
Moran, CA, Weissferdt, A, Kalhor, N et al. Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol. 2012;137:444–50.CrossRefGoogle ScholarPubMed
Moran, CA, Suster, S. Thymic epithelial neoplasms: a comprehensive review of diagnosis and treatment. Preface. Hematol Oncol Clin North Am. 2008;22:xi–xii.CrossRefGoogle ScholarPubMed
Marchevsky, AM, Wick, MR. Evidence-Based Pathology and Laboratory Medicine. 2011; New York: Springer.CrossRefGoogle Scholar
Marchevsky, AM, Gupta, R, Casadio, C et al. World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. Hum Pathol. 2010;41:1413–21.CrossRefGoogle ScholarPubMed
Marchevsky, AM, Gupta, R, McKenna, RJ et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer. 2008;112:2780–8.CrossRefGoogle ScholarPubMed
Detterbeck, FC, Nicholson, AG, Kondo, K et al. The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol. 2011;6:S1710–S1716.CrossRefGoogle ScholarPubMed
Suster, S, Moran, CA. Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm. Am J Surg Pathol. 1999;23:691–700.CrossRefGoogle ScholarPubMed
Weissferdt, A, Hernandez, JC, Kalhor, N et al. Spindle cell thymomas: an immunohistochemical study of 30 cases. Appl Immunohistochem Mol Morphol. 2011;19:329–35.CrossRefGoogle ScholarPubMed
Eimoto, T, Teshima, K, Shirakusa, T et al. Heterogeneity of epithelial cells and reactive components in thymomas: an ultrastructural and immunohistochemical study. Ultrastruct Pathol. 1986;10:157–73.CrossRefGoogle ScholarPubMed
Weissferdt, A, Moran, CA. Pax8 expression in thymic epithelial neoplasms: an immunohistochemical analysis. Am J Surg Pathol. 2011;35:1305–10.CrossRefGoogle ScholarPubMed
Cornea, R, Cimpean, AM, Simu, M et al. Clinical, morphological and immunohistochemical characterization of a recurrent B1 type thymoma. Rom J Morphol Embryol. 2012;53:639–43.Google ScholarPubMed
Chu, PG, Weiss, LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol. 2002;15:6–10.CrossRefGoogle ScholarPubMed
Cimpean, AM, Raica, M, Encica, S. Overexpression of cytokeratin 34beta E12 in thymoma: could it be a poor prognosis factor?Rom J Morphol Embryol. 1999;45:153–7.Google ScholarPubMed
Kojika, M, Ishii, G, Yoshida, J et al. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol. 2009;22:1341–50.CrossRefGoogle ScholarPubMed
Shiraishi, J, Nomori, H, Orikasa, H et al. Atypical thymoma (WHO B3) with neuroendocrine differentiation: report of a case. Virchows Arch. 2006;449:234–7.CrossRefGoogle ScholarPubMed
Giaccone, G, Rajan, A, Ruijter, R et al. Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas. J Thorac Oncol. 2009;4:1270–3.CrossRefGoogle ScholarPubMed
Kaira, K, Murakami, H, Serizawa, M et al. MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma. Virchows Arch. 2011;458:615–20.CrossRefGoogle ScholarPubMed
Khoury, T, Chandrasekhar, R, Wilding, G et al. Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma. Int J Exp Pathol. 2011;92:87–96.CrossRefGoogle ScholarPubMed
Kojika, M, Ishii, G, Yoshida, J et al. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol. 2009;22:1341–50.CrossRefGoogle ScholarPubMed
Laeng, RH, Eimoto, T, Kuo, TT et al. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?Pathol Res Pract. 2006;202:697–704.CrossRefGoogle ScholarPubMed
Shiraishi, J, Nomori, H, Orikasa, H et al. Atypical thymoma (WHO B3) with neuroendocrine differentiation: report of a case. Virchows Arch. 2006;449:234–7.CrossRefGoogle ScholarPubMed
Yoshino, N, Kubokura, H, Yamauchi, S et al. Type B3 thymic epithelial tumor in an adolescent detected by immunohistochemical staining for CD5, CD99, and KIT (CD117): a case report. Ann Thorac Cardiovasc Surg. 2009;15:324–7.Google Scholar
Verghese, ET, den Bakker, MA, Campbell, A et al. Interobserver variation in the classification of thymic tumours–a multicentre study using the WHO classification system. Histopathology. 2008;53:218–23.CrossRefGoogle ScholarPubMed
Rieker, RJ, Muley, T, Klein, C et al. An institutional study on thymomas and thymic carcinomas: experience in 77 patients. Thorac Cardiovasc Surg. 2008;56:143–7.CrossRefGoogle ScholarPubMed
Kendall, MD. The morphology of perivascular spaces in the thymus. Thymus. 1989;13:157–64.Google ScholarPubMed
Nonaka, D, Rosai, J. Is there a spectrum of cytologic atypia in type A thymomas analogous to that seen in type B thymomas? A pilot study of 13 cases. Am J Surg Pathol 2012;36:889–94.CrossRefGoogle Scholar
Vladislav, IT, Gokmen-Polar, Y, Kesler, KA, et al. The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases. Mod Pathol 2013 Aug; 26(8):1059–64.CrossRefGoogle ScholarPubMed
Kirchner, T, Schalke, B, Buchwald, J et al. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 1992;16:1153–69.CrossRefGoogle ScholarPubMed
Nobre, AR, Albergaria, A, Schmitt F. p40: a p63 isoform useful for lung cancer diagnosis – a review of the physiological and pathological role of p63. Acta Cytol. 2013;57:1–8.CrossRefGoogle ScholarPubMed
Moran, CA, Suster, S. On the histologic heterogeneity of thymic epithelial neoplasms. Impact of sampling in subtyping and classification of thymomas. Am J Clin Pathol. 2000;114:760–6.CrossRefGoogle ScholarPubMed
Moran, CA, Walsh, G, Suster, S et al. Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol. 2012;137:451–61.CrossRefGoogle ScholarPubMed
Detterbeck, FC, Moran, C, Huang, J et al. Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol. 2011;6:S1730–S1738.CrossRefGoogle ScholarPubMed
Marchevsky, A, Marx, A, Strobel, P et al. Policies and reporting guidelines for small biopsy specimens of mediastinal masses. J Thorac Oncol. 2011;6:S1724–S1729.CrossRefGoogle ScholarPubMed
Cho, KJ, Ha, CW, Koh, JS et al. Thymic carcinoid tumor combined with thymoma–neuroendocrine differentiation in thymoma?J Korean Med Sci. 1993;8:458–63.CrossRefGoogle ScholarPubMed
Steger, C, Steiner, HJ, Moser, K et al. A typical thymic carcinoid tumour within a thymolipoma: report of a case and review of combined tumours of the thymus. BMJ Case Rep. 2010. .
Suster, S, Moran, CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol. 1996;20:1469–80.CrossRefGoogle ScholarPubMed
Suster, S, Moran, CA, Chan, JK. Thymoma with pseudosarcomatous stroma: report of an unusual histologic variant of thymic epithelial neoplasm that may simulate carcinosarcoma. Am J Surg Pathol. 1997;21:1316–23.CrossRefGoogle ScholarPubMed
Kang, G, Yoon, N, Han, J et al. Metaplastic thymoma: report of 4 cases. Korean J Pathol. 2012;46:92–5.CrossRefGoogle ScholarPubMed
Liu, B, Rao, Q, Zhu, Y et al. Metaplastic thymoma of the mediastinum. A clinicopathologic, immunohistochemical, and genetic analysis. Am J Clin Pathol. 2012;137:261–9.CrossRefGoogle ScholarPubMed
Lu, HS, Gan, MF, Zhou, T et al. Sarcomatoid thymic carcinoma arising in metaplastic thymoma: a case report. Int J Surg Pathol. 2011;19:677–80.CrossRefGoogle ScholarPubMed
Moritani, S, Ichihara, S, Mukai, K et al. Sarcomatoid carcinoma of the thymus arising in metaplastic thymoma. Histopathology. 2008;52:409–11.CrossRefGoogle ScholarPubMed
Poorabdollah, M, Mehdizadeh, E, Mohammadi, F et al. Metaplastic thymoma: report of an unusual thymic epithelial neoplasm arising in the wall of a thymic cyst. Int J Surg Pathol. 2009;17:51–4.CrossRefGoogle ScholarPubMed
Yoneda, S, Marx, A, Muller-Hermelink, HK. Low-grade metaplastic carcinomas of the thymus: biphasic thymic epithelial tumors with mesenchymal metaplasia–an update. Pathol Res Pract. 1999;195:555–63.CrossRefGoogle ScholarPubMed
Strobel, P, Marino, M, Feuchtenberger, M et al. Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development. J Pathol. 2005;207:72–82.CrossRefGoogle ScholarPubMed
Suster, S, Moran, CA. Micronodular thymoma with lymphoid B-cell hyperplasia: clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm. Am J Surg Pathol. 1999;23:955–62.CrossRefGoogle ScholarPubMed
El, MF, Braham, E, Ayadi, A et al. Micronodular thymoma with lymphoid stroma: report of two cases and particular association with thymic lymphoid hyperplasia in one case. Pathology. 2006;38:586–8.Google ScholarPubMed
Mende, S, Moschopulos, M, Marx, A et al. Ectopic micronodular thymoma with lymphoid stroma. Virchows Arch. 2004;444:397–9.CrossRefGoogle ScholarPubMed
Moran, CA, Koss, MN. Rhabdomyomatous thymoma. Am J Surg Pathol. 1993;17:633–6.CrossRefGoogle ScholarPubMed
de Queiroga, EM, Chikota, H, Bacchi, CE et al. Rhabdomyomatous carcinoma of the thymus. Am J Surg Pathol. 2004;28:1245–50.Google ScholarPubMed
Salih, DM, Ceyhan, K, Deveci, G et al. Pericardial rhabdomyomatous spindle cell thymoma with mucinous cystic degeneration. Histopathology. 2001;38:479–81.CrossRefGoogle Scholar
Moran, CA, Suster, S. “Ancient” (sclerosing) thymomas: a clinicopathologic study of 10 cases. Am J Clin Pathol. 2004;121:867–71.CrossRefGoogle ScholarPubMed
Kuo, T. Sclerosing thymoma–a possible phenomenon of regression. Histopathology. 1994;25:289–91.CrossRefGoogle Scholar
Weissferdt, A, Moran, CA. Thymomas with prominent glandular differentiation: a clinicopathologic and immunohistochemical study of 12 cases. Hum Pathol. 2013; 44:1612–16.CrossRefGoogle ScholarPubMed
Kalhor, N, Suster, S, Moran, CA. Spindle cell thymomas (WHO Type A) with prominent papillary and pseudopapillary features: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol. 2011;35:372–7.CrossRefGoogle ScholarPubMed
Onuki, T, Iguchi, K, Inagaki, M et al. [Lipofibroadenoma of the thymus]. Kyobu Geka. 2009;62:395–8.Google Scholar
Moran, CA, Suster, S, Gil, J et al. Morphometric analysis of germinal centers in nonthymomatous patients with myasthenia gravis. Arch Pathol Lab Med. 1990;114:689–91.Google ScholarPubMed
Sherer, Y, Bardayan, Y, Shoenfeld, Y. Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases (Review). Int J Oncol. 1997;10:939–43.Google Scholar
Willcox, N, Schluep, M, Ritter, MA et al. Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset?Am J Pathol. 1987;127:447–60.Google ScholarPubMed
Hofmann, WJ, Moller, P, Otto, HF. Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study. Klin Wochenschr. 1987;65:53–60.CrossRefGoogle ScholarPubMed
Alpert, LI, Papatestas, A, Kark, A et al. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch Pathol. 1971;91:55–61.Google ScholarPubMed
Papatestas, AE, Alpert, LI, Osserman, KE et al. Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941–1969. Am J Med. 1971;50:465–74.CrossRefGoogle ScholarPubMed
Pascoe, HR, Miner, MS. An ultrastructural study of nine thymomas. Cancer. 1976;37:317–26.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
Pedraza, MA. Thymoma immunological and ultrastructural characterization. Cancer. 1977;39:1455–61.3.0.CO;2-#>CrossRefGoogle ScholarPubMed
Bloodworth, JM, Hiratsuka, H, Hickey, RC et al. Ultrastructure of the human thymus, thymic tumors, and myasthenia gravis. Pathol Annu. 1975;10:329–91.Google ScholarPubMed
Low, TL. Biochemical characterization of thymic hormones in thymoma tissues. Thymus. 1990;15:93–105.Google ScholarPubMed
Low, TL, Goldstein, AL. Thymic hormones: an overview. Methods Enzymol. 1985;116:213–19.CrossRefGoogle ScholarPubMed
Chollet, P, Plagne, R, Fonck, Y et al. Thymoma with hypersecretion of thymic hormone. Thymus. 1981;3:321–34.Google ScholarPubMed
Ranelletti, FO, Iacobelli, S, Carmignani, M et al. Glucocorticoid receptors and in vitro corticosensitivity in human thymoma. Cancer Res. 1980;40:2020–5.Google ScholarPubMed
Ranelletti, FO, Carmignani, M, Marchetti, P et al. Estrogen binding by neoplastic human thymus cytosol. Eur J Cancer. 1980;16:951–5.CrossRefGoogle ScholarPubMed
Davies, SE, Macartney, JC, Camplejohn, RS et al. DNA flow cytometry of thymomas. Histopathology. 1989;15:77–83.CrossRefGoogle ScholarPubMed
Kristoffersson, U, Heim, S, Mandahl, N et al. Multiple clonal chromosome aberrations in two thymomas. Cancer Genet Cytogenet. 1989;41:93–8.CrossRefGoogle ScholarPubMed
Abraham, KM, Levin, SD, Marth, JD et al. Thymic tumorigenesis induced by overexpression of p56lck. Proc Natl Acad Sci U S A. 1991;88:3977–81.CrossRefGoogle ScholarPubMed
Barthlott, T, Keller, MP, Krenger, W et al. A short primer on early molecular and cellular events in thymus organogenesis and replacement. Swiss Med Wkly. 2007;137 Suppl 155:9S–13S.Google Scholar
Girard, N. Chemotherapy and targeted agents for thymic malignancies. Expert Rev Anticancer Ther. 2012;12:685–95.CrossRefGoogle ScholarPubMed
Manley, NR. Thymus organogenesis and molecular mechanisms of thymic epithelial cell differentiation. Semin Immunol. 2000;12:421–8.CrossRefGoogle ScholarPubMed
Sasaki, H, Ide, N, Fukai, I et al. Gene expression analysis of human thymoma correlates with tumor stage. Int J Cancer. 2002;101:342–7.CrossRefGoogle ScholarPubMed
Weissferdt, A, Wistuba, II, Moran, CA. Molecular aspects of thymic carcinoma. Lung Cancer. 2012;78:127–32.CrossRefGoogle ScholarPubMed
Girard, N. Thymic tumors: relevant molecular data in the clinic. J Thorac Oncol. 2010;5:S291–S295.CrossRefGoogle ScholarPubMed
Mentzer, SJ, Swanson, SJ, DeCamp, MM et al. Mediastinoscopy, thoracoscopy, and video-assisted thoracic surgery in the diagnosis and staging of lung cancer. Chest. 1997;112:239S–241S.CrossRefGoogle ScholarPubMed
Vilmann, P, Puri, R. The complete ‘‘medical’’ mediastinoscopy (EUS-FNA + EBUS-TBNA). Minerva Med. 2007;98:331–8.Google Scholar
Zakkar, M, Tan, C, Hunt, I. Is video mediastinoscopy a safer and more effective procedure than conventional mediastinoscopy?Interact Cardiovasc Thorac Surg. 2012;14:81–4.CrossRefGoogle ScholarPubMed
Girard, N, Shen, R, Guo, T et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res. 2009;15:6790–9.CrossRefGoogle ScholarPubMed
Zakowski, MF, Huang, J, Bramlage, MP. The role of fine needle aspiration cytology in the diagnosis and management of thymic neoplasia. J Thorac Oncol. 2010;5:S281–S285.CrossRefGoogle ScholarPubMed
Bergh, NP, Gatzinsky, P, Larsson, S et al. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg. 1978;25:91–8.CrossRefGoogle ScholarPubMed
Masaoka, A. Staging system of thymoma. J Thorac Oncol. 2010;5:S304–S312.CrossRefGoogle ScholarPubMed
Gupta, R, Marchevsky, AM, McKenna, RJ et al. Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med. 2008;132:926–30.Google Scholar
Blumberg, D, Port, JL, Weksler, B et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60:908–13.CrossRefGoogle ScholarPubMed
Koppitz, H, Rockstroh, JK, Schuller, H et al. State-of-the-art classification and multimodality treatment of malignant thymoma. Cancer Treat Rev. 2012;38:540–8.CrossRefGoogle ScholarPubMed
Lucchi, M, Mussi, A. Surgical treatment of recurrent thymomas. J Thorac Oncol. 2010;5:S348–S351.CrossRefGoogle ScholarPubMed
Detterbeck, FC. Evaluation and treatment of stage I and II thymoma. J Thorac Oncol. 2010;5:S318–S322.CrossRefGoogle Scholar
Eng, TY, Thomas, CR. Radiation therapy in the management of thymic tumors. Semin Thorac Cardiovasc Surg. 2005;17:32–40.CrossRefGoogle ScholarPubMed
Gomez, D, Komaki, R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol. 2010;5:S336–S343.CrossRefGoogle ScholarPubMed
Mangi, AA, Wain, JC, Donahue, DM et al. Adjuvant radiation of stage III thymoma: is it necessary?Ann Thorac Surg. 2005;79:1834–9.CrossRefGoogle ScholarPubMed
Vasamiliette, J, Hohenberger, P, Schoenberg, S et al. Treatment monitoring with 18F-FDG PET in metastatic thymoma after 90Y-Dotatoc and selective internal radiation treatment (SIRT). Hell J Nucl Med. 2009;12:271–3.Google Scholar
Weksler, B, Shende, M, Nason, KS et al. The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study. Ann Thorac Surg. 2012;93:1822–8.CrossRefGoogle ScholarPubMed
Chahinian, AP. Chemotherapy of thymomas and thymic carcinomas. Chest Surg Clin N Am. 2001;11:447–56.Google ScholarPubMed
Chahinian, AP, Holland, JF, Bhardwaj, S. Chemotherapy for malignant thymoma. Ann Intern Med. 1983;99:736.Google ScholarPubMed
Dosios, T, Nikou, GC, Toubanakis, C et al. Multimodality treatment of neuroendocrine tumors of the thymus. Thorac Cardiovasc Surg. 2005;53:305–9.CrossRefGoogle ScholarPubMed
Filosso, PL, Actis Dato, GM, Ruffini, E et al. Multidisciplinary treatment of advanced thymic neuroendocrine carcinoma (carcinoid): report of a successful case and review of the literature. J Thorac Cardiovasc Surg. 2004;127:1215–19.CrossRefGoogle ScholarPubMed
Loehrer, PJ, Wang, W, Johnson, DH et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol. 2004;22:293–9.CrossRefGoogle ScholarPubMed
Loehrer, PJ, Wick, MR. Thymic malignancies. Cancer Treat Res. 2001;105:277–302.CrossRefGoogle ScholarPubMed
Schmitt, J, Loehrer, PJ. The role of chemotherapy in advanced thymoma. J Thorac Oncol. 2010;5:S357–S360.CrossRefGoogle ScholarPubMed
Nikolic, DM, Nikolic, AV, Lavrnic, DV et al. Childhood-onset myasthenia gravis with thymoma. Pediatr Neurol. 2012;46:329–31.CrossRefGoogle ScholarPubMed
Iorio, R, Evoli, A, Lauriola, L et al. A B3 type-thymoma in a 7-year-old child with myasthenia gravis. J Thorac Oncol. 2012;7:937–8.CrossRefGoogle Scholar
Dehner, LP, Martin, SA, Sumner, HW. Thymus related tumors and tumor-like lesions in childhood with rapid clinical progression and death. Hum Pathol. 1977;8:53–66.CrossRefGoogle ScholarPubMed
Welch, KJ, Tapper, D, Vawter, GP. Surgical treatment of thymic cysts and neoplasms in children. J Pediatr Surg. 1979;14:691–8.CrossRefGoogle ScholarPubMed
Bowie, PR, Teixeira, OH, Carpenter, B. Malignant thymoma in a nine-year-old boy presenting with pleuropericardial effusion. J Thorac Cardiovasc Surg. 1979;77:777–81.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×